Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50-mg Film-Coated Tablet.
UCB Pharma, Braine l'Alleud, Belgium.
Christian
C
Otoul
UCB Pharma, Braine l'Alleud, Belgium.
Shikiko
S
Watanabe
UCB Pharma, Braine l'Alleud, Belgium.
Suzanne
S
McCabe
UCB Pharma, Braine l'Alleud, Belgium.
Armel
A
Stockis
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D001682:Biological Availability; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011760:Pyrrolidinones / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D012996:Solutions; D013607:Tablets; D013810:Therapeutic Equivalency; D055815:Young Adult
D000927:Anticonvulsants; D011760:Pyrrolidinones; D012996:Solutions; D013607:Tablets; C482793:brivaracetam